Neurodegenerative diseases and transglutaminase.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Amyloid-like protein inclusions in tobacco transgenic plants.PloS one · 2010
   Article
2. Calmodulin regulates transglutaminase 2 cross-linking of huntingtin.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2004
   Article
3. Transglutaminase type II plays a protective role in hepatic injury.The American journal of pathology · 2003
   Article
4. Prospects for the pharmacotherapy of amyotrophic lateral sclerosis : old strategies and new paradigms for the third millennium.CNS drugs · 2003
   Review
5. Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity.Proceedings of the National Academy of Sciences of the United States of America · 2002
   Article
6. Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei.Proceedings of the National Academy of Sciences of the United States of America · 1999
   Article
7. Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length.Proceedings of the National Academy of Sciences of the United States of America · 1997
   Article
8. Aggregation of expanded huntingtin in the brains of patients with Huntington disease.Prion
   Review

Corrections and comments

• Comment on
  Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system.1996
• Erratum issued

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as